Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

DEN DANSKE ZONETERAPEUT SKOLE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0% 2.0%   Bankruptcy risk   2.9% 2.2% 1.9% 2.6% 29.2% 2.7% 16.7% 16.7%   Credit score (0-100)   59 68 70 60 1 59 10 10   Credit rating   BBB BBB A BBB C BBB BB BB   Credit limit (kDKK)   0.0 0.1 0.5 0.0 -0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,390 1,955 1,951 2,066 1,128 1,300 0.0 0.0   EBITDA   662 811 725 812 -1,162 1,178 0.0 0.0   EBIT   662 811 725 812 -1,162 1,178 0.0 0.0   Pre-tax profit (PTP)   698.2 848.6 744.3 817.4 -1,168.1 1,172.1 0.0 0.0   Net earnings   543.3 660.5 579.4 637.2 -919.0 907.6 0.0 0.0   Pre-tax profit without non-rec. items   698 849 744 817 -1,168 1,172 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   717 878 957 894 -146 761 11.2 11.2   Interest-bearing liabilities   0.0 1.2 1.2 1.2 0.0 42.4 0.0 0.0   Balance sheet total (assets)   1,523 1,822 1,891 1,730 1,414 2,308 11.2 11.2   Net Debt   -614 -129 -520 -166 -145 -1,136 -11.2 -11.2     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,390 1,955 1,951 2,066 1,128 1,300 0.0 0.0   Gross profit growth   -2.6% 40.7% -0.2% 5.9% -45.4% 15.2% -100.0% 0.0%   Employees   2 1 1 1 1 1 0 0   Employee growth %   0.0% -50.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,523 1,822 1,891 1,730 1,414 2,308 11 11   Balance sheet change%   13.6% 19.6% 3.8% -8.5% -18.3% 63.3% -99.5% 0.0%   Added value   662.1 811.0 725.0 811.6 -1,162.2 1,178.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   47.6% 41.5% 37.2% 39.3% -103.0% 90.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   49.1% 48.6% 39.1% 44.8% -70.6% 60.9% 0.0% 0.0%   ROI %   157.6% 101.9% 78.9% 87.6% -259.5% 293.3% 0.0% 0.0%   ROE %   121.9% 82.8% 63.1% 68.8% -79.6% 83.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   69.9% 70.0% 72.4% 74.5% -548.9% 76.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -92.7% -15.8% -71.8% -20.4% 12.5% -96.4% 0.0% 0.0%   Gearing %   0.0% 0.1% 0.1% 0.1% 0.0% 5.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% -6,025.3% -1,630.3% -474.9% 1,014.3% 31.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   4.8 4.6 5.0 5.4 40.2 9.7 0.0 0.0   Current Ratio   1.9 1.9 2.0 2.0 0.7 1.5 0.0 0.0   Cash and cash equivalent   613.9 129.7 521.5 166.7 145.4 1,178.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   686.3 846.8 926.2 863.3 -421.7 735.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   331 811 725 812 -1,162 1,178 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   331 811 725 812 -1,162 1,178 0 0   EBIT / employee   331 811 725 812 -1,162 1,178 0 0   Net earnings / employee   272 661 579 637 -919 908 0 0